GlassScriptPhysician profile
Rachel Raphael
NPI 1366641169
$9,701.50
in general payments reported to CMS, 2019-2025
17 companies · $90.36 in 2025
The $90.36 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $99.74 · 2022: $318 · 2023: $9,165 · 2024: $29.02 · 2025: $90.36.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $8,500 · Travel and Lodging: $618 · Food and Beverage: $166.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $8,500.00 |
| Travel and Lodging | $617.92 |
| Food and Beverage | $166.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $9,254.73 | 2022-2023 | Davinci Xi, Da Vinci Surgical System |
| Thd America, INC. | $76.11 | 2022 | |
| Kerecis Limited | $53.54 | 2024-2025 | Kerecis Surgiclose, Kerecis Omega3 Marigen, Kerecis Graftguide |
| Ethicon US, LLC | $46.02 | 2022-2025 | Proximate |
| Smith+Nephew, INC. | $37.54 | 2022 | |
| Kci USA, INC. | $27.66 | 2023 | Prevena, V.A.C. Veraflo Cleanse Choice |
| Takeda Pharmaceuticals U.S.A., INC. | $26.66 | 2021 | |
| Davol INC. | $21.57 | 2021 | |
| Daiichi Sankyo INC. | $21.21 | 2021 | |
| Elucent Medical | $21.09 | 2025 | |
| Pacira Pharmaceuticals Incorporated | $20.71 | 2022 | |
| Medtronic, INC. | $19.45 | 2022 | |
| Integra Lifesciences Corporation | $15.99 | 2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Merit Medical Systems INC | $15.90 | 2021 | |
| Merck Sharp & Dohme LLC | $15.14 | 2023 | Lynparza, Keytruda |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Braintree Laboratories, INC. | $14.40 | 2021 | |
| Heron Therapeutics, INC. | $13.78 | 2024 | Zynrelef |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rachel Raphael listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.